Skip to main content
. 2021 Apr 15;44(6):1402–1409. doi: 10.2337/dc20-2089

Figure 2.

Figure 2

Levels of anti–MGO-apoB100 (A) and anti–MGO-p5 (B) in type 1 diabetes with no/background retinopathy (n = 49) and proliferative retinopathy (n = 34). The values are presented as median (IQR). Absorbance was measured at 405 nm and is presented as absorbance units in percentage compared to control plasma pool. *P < 0.05 (Kruskal-Wallis test).